Paion AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PAIOF research report →
About the company
Paion AG is a specialized biopharmaceutical company that operates globally, focusing on the development and commercialization of medications intended for hospital settings, specifically for sedation, anesthesia, and critical care management. Its primary product in development is Remimazolam, an ultra-short-acting intravenous benzodiazepine-class drug serving as both a sedative and an anesthetic, which is currently undergoing clinical trials for applications in procedural sedation, general anesthesia, and intensive care unit sedation. The company's pipeline further includes Angiotensin II, a vasoconstrictor designed for adults experiencing refractory low blood pressure due to septic or other forms of distributive shock, and Eravacycline, a novel fluorocycline antibiotic aimed at treating complicated intra-abdominal infections in adults.
- CEO
- Gregor Siebert
- IPO
- 2009
- Employees
- 64
- HQ
- Aachen, DE
Price Chart
- Market Cap
- $75.26K
- P/E
- -4.43
- P/S
- 0.08
- P/B
- 0.39
- EV/EBITDA
- 3.46
- Div Yield
- 0.00%
- Gross Margin
- 94.10%
- Op Margin
- 4.53%
- Net Margin
- -1.74%
- ROE
- -8.51%
- ROIC
- 5.58%
- Revenue
- $33.25M · 366.44%
- Net Income
- $-579,000 · 97.34%
- EPS
- $-0.08 · 97.39%
- Op Income
- $1.50M
- FCF YoY
- 110.78%
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 4.16
- Avg Volume
- 18.72K
Get TickerSpark's AI analysis on PAIOF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PAIOF coverage
Recent articles, reports, and earnings notes.
No research on PAIOF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PAIOF report →Similar companies
Peers in the same neighborhood.